Table 1.
Subjects (n = 63) | |||||
---|---|---|---|---|---|
Stable NC (n=15) |
NC to MCI (n=14) |
Stable MCI (n=16) |
MCI/AD to AD (n=18) |
P-value | |
Baseline age (years) | 83.6±3.9 | 83.0±3.0 | 84.8±4.1 | 83.5±4.2 | 0.6691 |
Gender (F, %) | 8 (53%) | 8 (57%) | 10 (63%) | 12 (67%) | 0.8733 |
Follow-up Time (years) | 2.9±1.7 | 2.5±1.8 | 2.9±1.8 | 1.9±1.3 | 0.5616 |
Education (years) |
15.1±2.6 | 14.1±2.7 | 15.4±2.7 | 13.1±4.4 | 0.1020 |
Hypertension (%) | 2 (13%) | 7 (50%) | 6 (43%) | 8 (57%) | 0.1174 |
Diabetes (%) | 1 (7%) | 2 (14%) | 1 (7%) | 2 (14%) | 0.8585 |
Heart Disease (%) | 2 (13%) | 4 (29%) | 3 (21%) | 2 (14%) | 0.7088 |
Baseline 3MSE scores | 95.7±2.4 | 95.8±4.2 | 96.0±2.7 | 87.5±6.5 | 0.0003 |
Follow-up 3MSE scores* | 95.4±4.6 (n’=14) | 95.1±4.2 (n’=13) | 95.5±3.4 (n’=15) | 84.6±7.3 (n’=16) | 0.0269 |
3MSE change* | −0.2±3.9 (n’=14) | −0.8±2.0 (n’=13) | −0.6±2.7 (n’=15) | −2.3±4.3 (n’=16) | 0.0362 |
3MSE scores were not completed for all the subjects at the follow-up. The actual number of subjects with the 3MSE scores measured is indicated inside the brackets.